AtlasXomics
PrivateLast Round
Grant
Apr 8, 2025
Total Funding Raised
$15.68M
Company Overview
AtlasXomics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Grant round in April 2025.
AtlasXomics is a biotechnology company that develops a spatial epigenome technology platform designed to provide multi-omics tissue atlases for researchers and clinicians.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtlasXomics Comparables
Compare AtlasXomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vizgen | 77% | |
| OmicInsight Corporation | 74% | |
| Takara Holdings Inc. | 74% |
For institutional investors. Book with your work email.
AtlasXomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 8, 2025 | ||||
| Grant | Sep 19, 2023 | ||||
| Grant | Sep 16, 2022 | ||||
| Grant | May 1, 2022 | ||||
| Series A | Feb 8, 2022 | ||||
Seed | Mar 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AtlasXomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Connecticut Innovations | Seed, Series A |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Elm Street Ventures | Seed |
| FORGE | Grant |
| Broadfield Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2025
$70K grant received from FORGE.
- Sep 19, 2023
$1.8M grant from the National Cancer Institute
For institutional investors. Book with your work email.
AtlasXomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AtlasXomics's valuation, stock price, and market status.
Is AtlasXomics a public or private company?
AtlasXomics is a private company.
What is the current stock price of AtlasXomics?
AtlasXomics is a private company, so its shares have no public market price. Caplight tracks AtlasXomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AtlasXomics worth (valuation)?
Valuation information for AtlasXomics is not publicly available.
Can I buy AtlasXomics stock?
AtlasXomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AtlasXomics's last funding round?
AtlasXomics's most recent funding round was Grant on April 8, 2025.
Who are the main investors in AtlasXomics?
Key investors in AtlasXomics include National Cancer Institute.
Will AtlasXomics IPO soon?
No public IPO plans have been announced for AtlasXomics.
How can I track AtlasXomics secondary market activity?
Caplight tracks bids, offers, and trades in AtlasXomics's shares on secondary markets.